ArcelorMittal Valuation
Is MT undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
6/6Valuation Score 6/6
Below Fair Value
Significantly Below Fair Value
Price-To-Sales vs Peers
Price-To-Sales vs Industry
Price-To-Sales vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of MT when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: MT (CHF29.19) is trading below our estimate of fair value (CHF86.26)
Significantly Below Fair Value: MT is trading below fair value by more than 20%.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for MT?
Other financial metrics that can be useful for relative valuation.
| What is MT's n/a Ratio? | |
|---|---|
| n/a | 0x |
| n/a | n/a |
| Market Cap | US$17.09b |
| Key Statistics | |
|---|---|
| Enterprise Value/Revenue | 0.4x |
| Enterprise Value/EBITDA | 5.4x |
| PEG Ratio | n/a |
Price to Sales Ratio vs Peers
How does MT's PS Ratio compare to its peers?
| Company | Forward PS | Estimated Growth | Market Cap |
|---|---|---|---|
| Peer Average | 3.8x | ||
EMSN EMS-CHEMIE HOLDING | 7.5x | 5.5% | CHF 15.8b |
STLN Swiss Steel Holding | 0.05x | n/a | CHF 141.7m |
GIVN Givaudan | 5.8x | 5.0% | CHF 41.4b |
HOLN Holcim | 1.7x | 4.9% | CHF 44.7b |
MT ArcelorMittal | 0.3x | 1.9% | CHF 15.5b |
Price-To-Sales vs Peers: MT is good value based on its Price-To-Sales Ratio (0.3x) compared to the peer average (3.8x).
Price to Earnings Ratio vs Industry
How does MT's PE Ratio compare vs other companies in the European Metals and Mining Industry?
Price-To-Sales vs Industry: MT is good value based on its Price-To-Sales Ratio (0.3x) compared to the European Metals and Mining industry average (0.7x).
Price to Sales Ratio vs Fair Ratio
What is MT's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
| Fair Ratio | |
|---|---|
| Current PS Ratio | 0.3x |
| Fair PS Ratio | 0.6x |
Price-To-Sales vs Fair Ratio: MT is good value based on its Price-To-Sales Ratio (0.3x) compared to the estimated Fair Price-To-Sales Ratio (0.6x).
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
| Date | Share Price | Average 1Y Price Target | Dispersion | High | Low | 1Y Actual price | Analysts |
|---|---|---|---|---|---|---|---|
| Current | n/a | CHF 27.25 0% | 14.3% | CHF 35.58 | CHF 21.91 | n/a | 13 |
| Sep ’25 | CHF 29.19 | CHF 27.15 -7.0% | 14.2% | CHF 35.55 | CHF 21.89 | n/a | 13 |
| Aug ’25 | CHF 29.19 | CHF 28.07 -3.8% | 14.0% | CHF 36.20 | CHF 22.71 | n/a | 13 |
| Jul ’25 | CHF 29.19 | CHF 30.26 +3.7% | 13.1% | CHF 39.02 | CHF 25.16 | n/a | 13 |
| Jun ’25 | CHF 29.19 | CHF 31.24 +7.0% | 13.5% | CHF 39.61 | CHF 25.54 | n/a | 13 |
| May ’25 | CHF 29.19 | CHF 31.24 +7.0% | 13.3% | CHF 38.99 | CHF 25.34 | n/a | 12 |
| Apr ’25 | CHF 29.19 | CHF 31.26 +7.1% | 13.4% | CHF 39.55 | CHF 26.64 | n/a | 13 |
| Mar ’25 | CHF 29.19 | CHF 30.24 +3.6% | 13.1% | CHF 38.01 | CHF 25.91 | n/a | 13 |
| Feb ’25 | CHF 29.19 | CHF 29.28 +0.3% | 13.3% | CHF 37.28 | CHF 23.47 | n/a | 13 |
| Jan ’25 | CHF 29.19 | CHF 29.37 +0.6% | 14.1% | CHF 38.12 | CHF 23.31 | n/a | 13 |
| Dec ’24 | CHF 29.19 | CHF 28.37 -2.8% | 18.5% | CHF 38.60 | CHF 18.82 | n/a | 12 |
| Nov ’24 | CHF 29.19 | CHF 29.81 +2.1% | 18.8% | CHF 38.83 | CHF 19.30 | n/a | 12 |
| Oct ’24 | CHF 29.19 | CHF 32.37 +10.9% | 14.4% | CHF 40.11 | CHF 23.06 | n/a | 12 |
| Sep ’24 | CHF 29.19 | CHF 31.57 +8.1% | 14.0% | CHF 38.23 | CHF 22.44 | CHF 29.19 | 12 |
| Aug ’24 | CHF 29.19 | CHF 31.45 +7.7% | 14.1% | CHF 38.34 | CHF 22.59 | CHF 29.19 | 12 |
| Jul ’24 | CHF 29.19 | CHF 33.01 +13.1% | 13.5% | CHF 38.98 | CHF 24.65 | CHF 29.19 | 12 |
| Jun ’24 | CHF 29.19 | CHF 34.21 +17.2% | 16.8% | CHF 48.14 | CHF 24.85 | CHF 29.19 | 13 |
| May ’24 | CHF 29.19 | CHF 33.90 +16.1% | 16.8% | CHF 47.84 | CHF 24.54 | CHF 29.19 | 13 |
| Apr ’24 | CHF 29.19 | CHF 34.64 +18.7% | 15.8% | CHF 47.56 | CHF 24.92 | CHF 29.19 | 13 |
| Mar ’24 | CHF 29.19 | CHF 35.80 +22.6% | 16.8% | CHF 48.91 | CHF 26.12 | CHF 29.19 | 12 |
| Feb ’24 | CHF 29.19 | CHF 34.19 +17.1% | 18.0% | CHF 48.30 | CHF 24.33 | CHF 29.19 | 12 |
| Jan ’24 | CHF 29.19 | CHF 32.07 +9.9% | 20.5% | CHF 45.54 | CHF 20.79 | CHF 29.19 | 14 |
| Dec ’23 | CHF 29.19 | CHF 32.32 +10.7% | 21.0% | CHF 46.19 | CHF 21.09 | CHF 29.19 | 14 |
| Nov ’23 | CHF 29.19 | CHF 32.81 +12.4% | 21.9% | CHF 47.55 | CHF 22.20 | CHF 29.19 | 14 |
| Oct ’23 | CHF 29.19 | CHF 35.58 +21.9% | 21.0% | CHF 49.88 | CHF 22.12 | CHF 29.19 | 15 |
| Sep ’23 | CHF 29.19 | CHF 36.75 +25.9% | 19.0% | CHF 50.17 | CHF 26.81 | CHF 29.19 | 15 |
Analyst Forecast: Target price is more than 20% higher than the current share price and analysts are within a statistically confident range of agreement.